Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
287
-
Total shares
-
62.3M
-
Shares change
-
+1.22M
-
Total reported value, excl. options
-
$9.8B
-
Value change
-
+$244M
-
Put/Call ratio
-
0.59
-
Number of buys
-
160
-
Number of sells
-
-104
-
Price
-
$157.33
Significant Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q1 2019
308 filings reported holding BLUE - BLUEBIRD BIO INC - COM as of Q1 2019.
BLUEBIRD BIO INC - COM (BLUE) has 287 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.3M shares
.
Largest 10 shareholders include FMR LLC (8.24M shares), WELLINGTON MANAGEMENT GROUP LLP (7.31M shares), Capital Research Global Investors (6.67M shares), Capital International Investors (5.12M shares), VANGUARD GROUP INC (4.89M shares), BAILLIE GIFFORD & CO (4.48M shares), Capital World Investors (4.02M shares), BlackRock Inc. (2.98M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.54M shares), and STATE STREET CORP (1.16M shares).
This table shows the top 287 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.